Metalloestrogen
WikiDoc Resources for Metalloestrogen |
Articles |
---|
Most recent articles on Metalloestrogen Most cited articles on Metalloestrogen |
Media |
Powerpoint slides on Metalloestrogen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Metalloestrogen at Clinical Trials.gov Trial results on Metalloestrogen Clinical Trials on Metalloestrogen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Metalloestrogen NICE Guidance on Metalloestrogen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Metalloestrogen Discussion groups on Metalloestrogen Patient Handouts on Metalloestrogen Directions to Hospitals Treating Metalloestrogen Risk calculators and risk factors for Metalloestrogen
|
Healthcare Provider Resources |
Causes & Risk Factors for Metalloestrogen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch. Metalloestrogens are a class of inorganic xenoestrogens which can affect the gene expression of human cells responding to estrogen. Effects are related to the physiologic function of estrogen because metalloestrogens have shown affinity for estrogen receptors. Because they can mimic estrogen thus activating the receptor, they are considered harmful and potentially linked with breast cancer.[1] List of metalloestrogens include aluminium, antimony, arsenite, barium, cadmium, chromium (Cr(II)), cobalt, copper, lead, mercury, nickel, selenite, tin and vanadate.
References
- ↑ Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast J Appl Toxicol. 2006 May-Jun;26(3):191-7.